PharmaVOICE - 
May 2017
Purchase Issue

In Every Issue
Letter from the Editor
The act of giving In this month’s cover story, we [...]
By

Taren Grom, Editor

Upfront
Sandoz Names Winners of Healthcare Access Challenge Sandoz, a Novartis [...]
By

PharmaVOICE Staff

Innovator’s Corner
Harnessing the Body’s Own Pathways to Silence Genes Douglas Fambrough, [...]
By

Douglas Fambrough, Ph.D., President and CEO, Dicerna Pharmaceuticals

HealthTech
Pregnant Women, an Understudied Population, Get Insights App Trend Watch: [...]
By

PharmaVOICE Staff

Last Word
Better Monitoring of Opioids Purdue Pharma’s VP and Chief Medical [...]
By

Gail Cawkwell, M.D., Ph.D, VP and Chief Medical Officer, Purdue Pharma

On The Cover

Philanthropy: Beyond the Numbers
Pharmaceutical companies — and the industry as a whole — are at the top of many lists in terms of charitable giving, philanthropy, and corporate responsibility. Over the years, pharma has repeatedly been named as a top industry corporate donor, rivaled only by the finance industry. The Reputation Institute, The Chronicle of Philanthropy, The Conference [...]
By

PharmaVOICE Staff

Features

Behind the Brand — Lessons Learned
According to the global branding and design firm Landor, the process of managing brands — or brand governance — has changed dramatically in recent  years. The command-and-control model is obsolete in today’s more agile and dynamic marketplace. In this new world, multiple communities, including employees, partners, third-party influencers, and superfans, are actively encouraged to become [...]
By

Robin Robinson

HBA Rising Stars & Luminaries: A Vision of the Future
PharmaVOICE asked the nearly 100 industry executives identified by their companies as HBA Rising Stars and Luminaries to identify the biggest trends they believe will impact the industry in the next few years. Top on their lists are innovation and value. They also tackle the topics of big data, patient-centricity, and health and wellness. For [...]
By

PharmaVOICE Staff

Hepatitis Market Update
In just a few short years, hepatitis infections could go from a serious disease to one that will be rare. Pharmaceutical companies have done much to address hepatitis in recent years. Today, hepatitis B is preventable with vaccination, and recent advances in treatment have made hepatitis C curable. The National Academies Of Sciences, Engineering, and [...]
By

Denise Myshko

Rare Recruitment
Efforts to bring treatments to market for the approximately 7,000 rare diseases affecting more than 350 million people globally have been stepped up in recent years. But in order to bring products to market, companies must conduct clinical trials with a large enough patient population — relative to the incidence of the disease — to [...]
By

Kim Ribbink

SHOWCASE FEATURE: mHealth: Seeing the Potential in mHealth
Mobile is ubiquitous. Consumers use mobile apps to search for information about everything from retail products to news and sports and, increasingly, to monitor their health. A report from comScore found that mobile now represents 65% of digital media time, and that desktop computers are becoming the secondary touchpoint for many U.S. consumers. This is [...]
By

PharmaVOICE Staff

The Impact of mHealth on Real-World Data Collection
Advancements in technology over the past five years have led to increased interest around the topic of mHealth — the monitoring and delivery of healthcare through mobile devices. Approximately 93% of us now own a mobile phone and, with an increased desire from the pharmaceutical industry to use electronic data capture over traditional paper methods, [...]
By
A Patient-Centric Approach to mHealth
The possibilities for mHealth solutions are vast and expanding, so how can pharmaceutical brands know how to enter the space, or even if they should? Consider Your Patients First Patients are actively searching for ways to live healthier lives, prevent illness, manage chronic conditions, and keep their healthcare costs down. Today’s patients, particularly those in [...]
By

Dara Liguori, Digital Engagement Strategist, Ogilvy CommonHealth Worldwide, part of WPP Health & Wellness

mHealth Evolution
Ten years after the launch of Apple’s iPhone in 2007, mobile healthcare (mHealth) technology and consumer adoption continues to advance. mHealth is a general term for the use of mobile wireless technology for medical care, health, and fitness. As the global population moves from being digitally naïve to digitally savvy, mHealth will likely become mainstream [...]
By

Brandie Linfante, VP, Digital Engagement Strategy, Ogilvy CommonHealth Worldwide, part of WPP Health & Wellness

Speak Out
Welcome to the Jungle: The Dilemma of the Healthcare Challenger Brand Marketing a pharmaceutical product or medical device to a healthcare professional audience has changed radically, even for market leaders and establishment brands. But for challenger brands—the brands with something to prove, obstacles to overcome, perceptions to change—the dilemma is even bigger. They need to [...]
By

Frank X. Powers, Managing Partner, Elevate Healthcare

FEEDBACK